David Sinclair: The Biology of Slowing & Reversing Aging | Episode 52 In this episode, I am joined by Dr
They went on to investigate the effect of this SNP on Slc1A1 mRNA expression in post-mortem tissue from control patients and from schizophrenics (not from OCD patients)
Dr Micklewright said: I am seeing more private businesses operating that offer these research-only peptides to patients and justify their practice by asking patients to sign disclaimers, accepting the risks and consenting to the treatment. Private clinic owner Dr Omar acknowledged this, saying: The key thing for users to understand is that these products are unlicensed and we make clear during the consenting process as to the implications of this informed consent is vital. In terms of delivering unlicensed peptide therapies safely, he added: We have a decent amount of information on how certain peptides work, some peptides are already licensed, and we have detailed information on dosing and side effects. At [our clinic], we have experience using peptides for various use scenarios and have access to a network of doctors across UK and the US where we can share data and knowledge on how to best use peptides, their side effects, and how to best dose them. Suppliers, meanwhile, maintain that they operate within current guidance
Thymosin Beta-4 (TB-500)# Thymosin Beta-4 (often studied as its fragment TB-500) is a 43-amino-acid polypeptide involved in actin sequestration, cell migration, and tissue repair
Research shows low-load BFR training can drive tendon adaptations comparable to high-load training: 14 weeks ~8% cross-sectional area & ~36% stiffness (Centner et al., 2019) Short-term pain relief (~45 min) enabling loading when it otherwise hurts (Korakakis et al., 2018) This means athletes and patients can achieve meaningful tendon stimulus and pain relief without high mechanical stress
